Related Experiment Videos
[HLA-linked susceptibility to intractable vasculitis syndrome]
1Department of Neuroscience and Immunology, Kumamoto University Graduate School of Medical Sciences.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
Summary
This study identifies specific human leukocyte antigen (HLA) haplotypes linked to Takayasu arteritis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCTD) in Japanese individuals.
Area of Science:
- Immunogenetics
- Human Leukocyte Antigen (HLA) complex
- Autoimmune diseases
Context:
- Autoimmune diseases like Takayasu arteritis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCTD) have complex etiologies.
- Genetic factors, particularly those within the Human Leukocyte Antigen (HLA) complex, are implicated in disease susceptibility.
- Understanding these genetic associations is crucial for elucidating disease mechanisms.
Purpose:
- To investigate the association between specific HLA class II gene haplotypes and susceptibility to Takayasu arteritis, RA, SLE, and MCTD in the Japanese population.
- To identify distinct HLA-linked genetic markers for each of these four autoimmune conditions.
Summary:
- Specific HLA class II haplotypes were significantly associated with susceptibility to Takayasu arteritis (HLA-B52-DRB1*1502-DRB5*0102-DQA1*0103-DQB1*0601-DPA1*02-DPB1*0401), RA (HLA-DRB1*0405-DQA1*0301-DQB1*0401), SLE (HLA-DRB1*1501-DRB5*0101-DQA1*0102-DQB1*0602), and MCTD (HLA-DRB1*0401-DRB4*0101-DQA1*0301-DQB1*0301) in a Japanese cohort.
- DNA-level typing of HLA class II genes was performed on 64 Takayasu arteritis patients, 204 RA patients, 53 SLE patients, and 64 MCTD patients, compared to healthy controls.
- The findings highlight distinct HLA-linked genetic backgrounds contributing to the susceptibility of these four distinct autoimmune diseases.
Impact:
- Provides evidence for specific HLA-associated genetic susceptibility factors in Takayasu arteritis, RA, SLE, and MCTD.
- Demonstrates the heterogeneity of HLA-linked genetic contributions across different autoimmune diseases.
- Informs future research into the pathogenetic mechanisms and potential therapeutic targets for these conditions.